Randomness and biospecificity: random copolymers are capable of biospecific molecular recognition in living systems
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Effects and risks of endocrine disrupting chemicals
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (82)
Show source-provided references
1. 1973 · Vol 1–7
2. Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity10.1016/0006-291X(83)90550-8 ↗
3. The unique antithrombin III binding domain of heparin: a lead to new synthetic antithrombotics10.1002/anie.199316713 ↗
4. Monod · 1970 · 1
5. Horbett · 1987
6. Vroman effects techniques, and philosophies10.1080/09205063.1991.9756657 ↗
7. Heparin bonding on colloïdal graphite surfaces10.1126/science.142.3597.1297 ↗
8. Non-thrombogenic plastic surfaces10.1126/science.152.3729.1625 ↗
9. Polyvinyl alcohol-heparin hydrogel ‘G’10.1152/jappl.1970.29.5.723 ↗
10. Covalent binding of biomolecules to radiation-grafted hydrogels on inert polymer surfaces10.1097/00002480-197201000-00003 ↗
11. Preparation and properties of heparin — poly (methylmethacrylate) copolymers
12. Intérêt du greffage radiochimique de monomères vinyliques pour améliorer l'hémocompatibilité de matériaux artificiels
13. Preparation and ESCA characterization with heparin-complexing poly (amidoamine) chains10.1016/0142-9612(82)90058-8 ↗
14. Immobilized heparin: spacer arm effects on biological interactions10.1016/0049-3848(82)90149-9 ↗
15. Properties of a heparin-poly (vinyl alcohol) hydrogel coating10.1002/jbm.820170212 ↗
16. A new nonthrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue
17. Covalent attachment of an arg-gly-asp sequence peptide to derivatizable polyacrylamide surfaces: support of fibroblast adhesion and long-term growth10.1016/0003-2697(88)90442-3 ↗
18. Covalent surface immobilization of arg-gly-asp- and tyr-ile-gly-ser-arg-containing peptides to obtain well-defined cell-adhesive substrates10.1016/0003-2697(90)90459-M ↗
19. Fibroblast attachment to Arg-Gly-Asp peptide-immobilized poly (γ-methyl Ll-glutamate)10.1163/156856294X00059 ↗
20. Surface properties of RGD-peptide grafted polyurethane blood copolymers: variable take-off angle and cold stage ESCA studies10.1163/156856293X00519 ↗
21. Analistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function10.1083/jcb.99.1.29 ↗
22. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule10.1038/309030a0 ↗
23. The binding of human blood platelets to fibrinogen; fibronectin; and Arg-Gly-Asp-derivatized Sephadex G-1010.1163/156856295X00472 ↗
24. New evidence and new hope concerning endothelial seeding of vascular grafts10.1016/S0002-9610(05)81070-0 ↗
25. Interaction of plasminogen and fibrinogen with model silica glass surfaces: adsorption from plasma and enzymatic activity studies10.1002/jbm.820280402 ↗
26. New heparin-like insoluble materials I10.1007/BF02364219 ↗
27. New heparin-like insoluble materials II10.1007/BF02364220 ↗
28. New heparin-like insoluble materials
29. Heparin-like activity of insoluble sulphonated polystyrene resins. Part III: Binding of dicarboxylic aminoacids10.1016/0142-9612(87)90062-7 ↗
30. Adsorption of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: II. Competition with the other plasma proteins10.1016/0142-9612(84)90007-3 ↗
31. Catalysis of the generation of thrombin-antithrombin complex by insoluble anticoagulant polystyrene derivatives10.1016/0142-9612(84)90008-5 ↗
32. Anticoagulant activity of amino acid modified polystyrene resins: influence of the carboxylic acid function10.1016/0142-9612(83)90048-0 ↗
33. Heparin-like tubings I. Preparation, characterization and biological in vitro activity assessment10.1016/0142-9612(88)90113-5 ↗
34. Heparin-like tubings III. Kinetics and mechanism of thrombin, antithrombin III and thrombin-antithrombin complex adsorption under controlled-flow conditions10.1016/0142-9612(88)90005-1 ↗
35. Heparinlike tubins II. Mechanism of the thrombin-antithrombin in reaction at the surface10.1016/0142-9612(88)90089-0 ↗
36. Antithrombic activity of some polysaccharide resins10.1016/0142-9612(82)90023-0 ↗
37. Anticoagulant hydrogels derived from crosslinked dextran. Part I: synthesis, characterization and antithrombic activity10.1016/0142-9612(87)90023-8 ↗
38. Antithrombogenic polymers10.1351/pac198456101335 ↗
39. Antithrombogenic activity of polysaccharide resins
40. Anticoagulant hydrogels derived from crosslinked dextran. Part II: mechanism of thrombin inactivation10.1016/0142-9612(87)90097-4 ↗
41. Anticoagulant activity of dextran derivatives. Part I: synthesis and characterization10.1016/0142-9612(84)90078-4 ↗
42. Anticoagulant activity of dextran derivatives. Part II: Mechanism of thrombin inactivation10.1016/0142-9612(85)90010-9 ↗
43. Anticomplementary activity of dextran derivatives10.1016/0142-9612(85)90040-7 ↗
44. Molecular weight dependency of the acquired anticomplementary and anticoagulant activities of specifically substituted dextrans10.1016/0142-9612(87)90111-6 ↗
45. Effect of substituted dextran derivative on complement activation in vivo10.1016/0142-9612(95)93581-W ↗
46. Polymeric drug and drug delivery systems
47. The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives10.1016/0161-5890(88)90064-8 ↗
48. Complement activation and adsorption of protein fragments by functionalized polymer surfaces in human serum10.1016/0142-9612(92)90024-I ↗
49. Antithrombic properties of insoluble modified polystyrene: Part I10.1016/0049-3848(84)90383-9 ↗
50. Thrombin purification by one-step preparative affinity chromatography on modified polystyrenes10.1016/S0021-9673(00)88994-3 ↗
51. High-performance affinity chromatography of human thrombin on modified polystyrene resins10.1016/0021-9673(86)80089-9 ↗
52. Affinity chromatography of thrombin on modified polystyrene resins10.1016/S0378-4347(00)80860-9 ↗
53. Affinity of antithrombin III for insoluble modified polystyrene10.1016/0049-3848(87)90210-6 ↗
54. Adsorption of thrombin from buffer and modified plasma to polystyrene resins containing sulphonate and sulphamide arginyl methyl ester groups10.1016/0142-9612(88)90068-3 ↗
55. Interaction of antithrombin III in purified solution and in plasma with insoluble modified polystyrene10.1016/0927-7765(93)80049-5 ↗
56. Adsorption of human antibodies to factor VIII: C to insoluble modified polystyrene from plasma10.1007/BF00703368 ↗
57. Tyrosyl sulfamide derivatives as ligands for affinity adsorption of anti FVIII antibodies10.1163/156856295X00085 ↗
58. Randomness and biospecificity: random copolymers are endowed with biospecific properties
59. Synthesis and characterization of phosphorylated polystyrene derivatives for use in chromatography: DNA-like and phospholipid-like behavior10.1002/pola.1991.080291001 ↗
60. Insoluble DNA-like phosphorylated polystyrene: specific interactions with anti-DNA antibodies from systemic lupus erythematosus patients10.1016/0142-9612(92)90096-7 ↗
61. Biospecific polymers: recognition of phosphorylated polystyrene derivatives by anti-DNA antibodies10.1163/156856297X00434 ↗
62. Reversible morphological and functional abnormalities of RINm5F cells cultured on polystyrene sulfonate beads10.1002/jbm.820210505 ↗
63. RINm5F cell culture on Sephadex derivatives10.1002/jbm.820270603 ↗
64. In vitro stimulation of human endothelial cells by derivatized dextrans10.1007/BF02634373 ↗
65. Human umbilical vein endothelial cell culture on heparin-like microcarriers10.1002/jbm.820270412 ↗
66. Conformational changes of fibronectin induced by polystyrene derivatives with a heparin-like function10.1002/jbm.820270509 ↗
67. Inhibition by heparin and derivatized dextrans of Staphylococcus aureus adhesion to fibronectin-coated biomaterials10.1163/156856292X00321 ↗
68. Biological and binding studies of acidic fibroblast growth factor in the presence of substituted dextran.10.1163/156856289X00064 ↗
69. Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF10.1002/jcp.1041500126 ↗
70. Affinity chromatography of fibroblast growth factors on substituted polystyrene10.1016/S0378-4347(00)82481-0 ↗
71. Derivatized dextran inhibition of smooth muscle cell proliferation10.1163/156856291X00241 ↗
72. Antiproliferative capacity of synthetic dexrtrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers10.1163/156856293X00104 ↗
73. Inhibitory effect of functional dextrans on rat arterial smooth muscle cell growth in vitro10.1016/0927-7765(94)80046-4 ↗
74. DNA-like and phospholipid-like phosphorylated polystyrene: characterization, distribution of functional groups, and calcium complexation properties10.1002/app.1994.070520111 ↗
75. Change of polymer reactivity in the course of macromolecular reaction10.1016/0014-3057(80)90214-1 ↗
76. 1983
77. Monoclonal anti-cardiolipin antibodies bind to DNA10.1002/eji.1830140609 ↗
78. Fractionation of low molecular weight heparin species and their interaction with antithrombin10.1016/S0021-9258(17)30159-X ↗
79. Inhibitory effect of substituted dextrans on MCF7 human breast cancer cell growth in vitro10.1097/00001813-199212000-00011 ↗
80. Affinity of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: I. In vitro adsorption studies10.1016/0142-9612(83)90031-5 ↗
81. Interactions of anticoagulant insoluble modified polystyrene resins with plasmatic proteins10.1016/0049-3848(82)90031-7 ↗
82. Needs, problems and opportunities in biomaterials and biocompatibility10.1016/0267-6605(92)90026-P ↗